Tradewinds LLC’s GSK GSK Stock Holding History

Tradewinds LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$390K	Sell	2,957 -1,402	-32%	-$74.1K	0.09%	149
2026 Q1	$225K	Hold	4,359	–	–	0.07%	136
2025 Q4	$214K	Buy	+4,359	New	+$203K	0.05%	202
2024 Q3	–	Sell	-5,973	Closed	-$230K	–	180
2024 Q2	$230K	Buy	+5,973	New	+$251K	0.07%	186
2023 Q3	$205K	Hold	5,666	–	–	0.12%	118
2023 Q2	$202K	Sell	5,666 -160	-3%	-$5.74K	0.12%	99
2023 Q1	$207K	Buy	5,826 +418	+8%	+$14.6K	0.13%	119
2022 Q4	$464K	Buy	+5,408	New	+$180K	0.3%	63
2022 Q3	–	Sell	-5,307	Closed	-$289K	–	109
2022 Q2	$289K	Buy	+5,307	New	+$293K	0.2%	90

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Tradewinds LLC's GSK Position: Q2 2026 in Review

Tradewinds LLC reduced its GSK (GSK) stake by 32% in Q2 2026, selling an estimated $74.1K and leaving 2,957 shares worth $390K. The position accounts for 0.09% of the portfolio, ranked #149.

Tradewinds LLC first reported a position in GSK in Q2 2022 and has held it in 9 quarters since. The position peaked at $464K in Q4 2022. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Tradewinds LLC held 2,957 shares of GSK worth $390K as of Q2 2026.
Tradewinds LLC sold 1,402 GSK shares in Q2 2026, an estimated $74.1K.
GSK made up 0.09% of Tradewinds LLC's portfolio in Q2 2026, its #149 holding.
Tradewinds LLC first reported a position in GSK in Q2 2022 and has held it in 9 quarters since.
Tradewinds LLC's GSK position peaked at $464K in Q4 2022.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Tradewinds LLC's 13F filing for Q2 2026, filed 14 Aug 2026.